Ivabradine — brands & medicines in Pakistan
Pakistan mein Ivabradine ke 1 brands available hain. Drug class: Cardiac Rate-Reducing Agent (If-Channel Inhibitor). Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Ivabradine is a cardiac rate-reducing agent (if-channel inhibitor) used in Pakistan for Stable Angina Pectoris (rate reduction), Chronic Heart Failure (with reduced ejection fraction), Inappropriate Sinus Tachycardia. Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Ivabradine?
Ivabradine is a cardiac rate-reducing agent (if-channel inhibitor) used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Ivabradine under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Stable Angina Pectoris (rate reduction)
- Chronic Heart Failure (with reduced ejection fraction)
- Inappropriate Sinus Tachycardia
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
5mg twice daily; may increase to 7.5mg twice daily after 3–4 weeks
This is a general adult guidance pattern based on the manufacturer's label for one of the Ivabradine brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Bradycardia — slow heart rate (Dhadkan dhimi hona)
- Phosphenes — transient luminous visual phenomena (Aankhon mein roshni dikhna)
- Headache (Sar dard)
- Dizziness (Chakkar)
Serious — stop and see a doctor
- Severe bradycardia — HR below 40 bpm (stop immediately)
- Atrial fibrillation
- Heart block (2nd or 3rd degree)
Important warnings
- Do not use in resting HR below 60 bpm before starting
- Avoid in severe hepatic impairment
- Avoid in pacemaker-dependent patients
- Visual disturbances (phosphenes) may occur
Ivabradine brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Ivabradine used for in Pakistan?
Ivabradine is commonly used for Stable Angina Pectoris (rate reduction), Chronic Heart Failure (with reduced ejection fraction), Inappropriate Sinus Tachycardia. It belongs to the cardiac rate-reducing agent (if-channel inhibitor) drug class.
What is the typical dosage of Ivabradine?
Typical adult dosing is described by manufacturers as: "5mg twice daily; may increase to 7.5mg twice daily after 3–4 weeks". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Ivabradine?
Common side effects include Bradycardia — slow heart rate (Dhadkan dhimi hona), Phosphenes — transient luminous visual phenomena (Aankhon mein roshni dikhna), Headache (Sar dard), Dizziness (Chakkar). Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Ivabradine and see a doctor?
Stop Ivabradine and seek urgent medical care if you experience: Severe bradycardia — HR below 40 bpm (stop immediately); Atrial fibrillation; Heart block (2nd or 3rd degree). These are serious signs that need immediate attention.
Is Ivabradine available without a prescription in Pakistan?
Prescription required.
What brands of Ivabradine are available in Pakistan?
1 brand of Ivabradine is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization